Ikarian Capital, LLC - Jun 30, 2025 SCHEDULE 13G/A Report for Forte Biosciences, Inc. Common Stock, $0.001 par value (FBRX)

Filing Manager: Ikarian Capital, LLC
Reporting Manager: Ikarian Capital, LLC
Security: Forte Biosciences, Inc. Common Stock, $0.001 par value
Symbol: FBRX
Shares outstanding: 12.4M shares
Disclosed Ownership: 618K shares
Ownership: 4.99%
Form type: SCHEDULE 13G/A
Date filed: 8/14/2025, 04:20 PM
Date of event: Jun 30, 2025
Previous filing: Feb 14, 2025
SEC: View on sec.gov

Reporting Managers (2)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
Ikarian Capital, LLC	4.99%	618K	0	618K	/s/ Neil Shahrestani	Neil Shahrestani, Sole Manager
Neil Shahrestani	4.99%	618K	0	618K	/s/ Neil Shahrestani	Neil Shahrestani